Literature DB >> 12413741

Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.

Masahiko Mihara1, Norihiro Nishimoto, Kazuyuki Yoshizaki, Takashi Suzuki.   

Abstract

In the present study, we examined the effect of anti-IL-6 receptor antibody (MR16-1) on humoral and cellular immune responses in mice. MR16-1 did not affect antigen-specific antibody production in either the primary or secondary response in mice immunized with dinitro-phenyl (DNP)-keyhole limpet haemocyanin (KLH) in saline. DNP-KLH immunization with complete Freund's adjuvant (CFA) markedly augmented anti-DNP antibody production and induced interleukin 6 (IL-6) production in serum. In this case, MR16-1 significantly suppressed antibody production and further increased serum IL-6 levels. Regarding the cellular response, we studied the effect on the delayed-type hypersensitivity (DTH) response. DTH response was induced in mice by the immunization with Mycobacterium butyricum with incomplete Freund's adjuvant and following antigen challenge into the footpad 14 days after immunization. When MR16-1 was injected immediately after immunization, the DTH response was significantly suppressed and enlargement of the spleen was also suppressed. This suppressive effect was observed, when MR16-1 was administered on day 0, but not on days 5 and 10. Again, serum IL-6 levels were much higher in MR16-1-treated mice compared with controls. Furthermore, spleen cells from control mice released IL-2 and INFgamma by the stimulation of antigen in vitro. In contrast, spleen cells from MR16-1-treated mice produced these cytokines at a marginal level. In contrast, MR16-1 did not suppress the DTH response, when it was injected immediately after antigen challenge. Our results suggest that IL-6 does not always involve antibody production, although IL-6 augments antibody production, and that IL-6 is essential for the induction of Th1 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413741     DOI: 10.1016/s0165-2478(02)00201-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice.

Authors:  Hiroto Yoshida; Misato Hashizume; Miho Suzuki; Masahiko Mihara
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

3.  A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases.

Authors:  Michael Lyman; Vincent Lieuw; Robyn Richardson; Anjuli Timmer; Christine Stewart; Steve Granger; Richard Woods; Michela Silacci; Dragan Grabulovski; Roland Newman
Journal:  J Biol Chem       Date:  2018-04-20       Impact factor: 5.157

Review 4.  The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.

Authors:  K Schinnerling; J C Aguillón; D Catalán; L Soto
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

5.  IL-6 is required for airway mucus production induced by inhaled fungal allergens.

Authors:  Wendy A Neveu; Jenna B Allard; Oliver Dienz; Matthew J Wargo; Gennaro Ciliberto; Laurie A Whittaker; Mercedes Rincon
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

6.  Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion.

Authors:  Minke H T Hartman; Inge Vreeswijk-Baudoin; Hilde E Groot; Kees W A van de Kolk; Rudolf A de Boer; Irene Mateo Leach; Rozemarijn Vliegenthart; Herman H W Sillje; Pim van der Harst
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

7.  Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.

Authors:  Peter Birner; Susanne Heider; Peter Petzelbauer; Peter Wolf; Christoph Kornauth; Madeleine Kuroll; Olaf Merkel; Günter Steiner; Tadamitsu Kishimoto; Stefan Rose-John; Afschin Soleiman; Richard Moriggl; Lukas Kenner
Journal:  Exp Dermatol       Date:  2016-02-13       Impact factor: 3.960

8.  The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice.

Authors:  Michihide Nishihara; Hiroki Aoki; Satoko Ohno; Aya Furusho; Saki Hirakata; Norifumi Nishida; Sohei Ito; Makiko Hayashi; Tsutomu Imaizumi; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.